Schisandra Adaptogenic Action and Stress Response

The term "adaptogen" was coined in 1947 by Soviet pharmacologist Nikolai Lazarev, working on resistance to non-specific stress at the Tomsk Polytechnic Institute and later at the All-Union Scientific Research Institute of Pharmaceutical Chemistry. Schisandra chinensis was one of the three botanicals — alongside Eleutherococcus senticosus (Siberian Eleuthero) and Rhodiola rosea — that anchored the Soviet adaptogen research program from the 1940s through the dissolution of the USSR in 1991. The Soviet evidence base included military trials in cosmonauts and submarine crews, athletic performance trials at the Leningrad Institute of Physical Culture, and pilot trials in mental-performance under stress at industrial worksites. The Chinese name wu wei zi — literally "five-flavor fruit" — reflects the unusual property that the dried berries simultaneously taste sweet, sour, bitter, pungent, and salty, traditionally interpreted as action on all five Wu Xing organ systems. Modern research has anchored the adaptogenic phenomenon in measurable HPA-axis modulation, cortisol normalization, nitric oxide signaling, and stress-protein induction.

Table of Contents

  1. Wu Wei Zi — The Five-Flavor Fruit Name Origin
  2. The Lazarev Adaptogen Definition (1947)
  3. The Soviet Adaptogen Research Program (1940s-1991)
  4. Schisandra Alongside Eleuthero and Rhodiola — The Three Pillars
  5. HPA-Axis Modulation and Cortisol Response
  6. Pilot Trials in Mental Performance Under Stress
  7. Nitric Oxide, HSP70, and the Stress-Protein Response
  8. Chronic Fatigue and Burnout Applications
  9. Combination Adaptogen Formulas (ADAPT-232 / SHR-5)
  10. Cautions and Practical Dosing
  11. Key Research Papers
  12. Connections

Wu Wei Zi — The Five-Flavor Fruit Name Origin

The Chinese name for Schisandra is wu wei zi — literally "five-flavor seed" or "five-flavor fruit" (五味子, where 五 means five, 味 means flavor or taste, and 子 means seed or fruit). The name reflects an immediately verifiable empirical observation: a single dried Schisandra berry, when chewed, sequentially expresses all five of the basic tastes recognized in traditional Chinese gastronomy: sweet, sour, bitter, pungent (acrid/spicy), and salty. Few other plant foods produce this complete spectrum in a single small berry.

In traditional Chinese medicine, each of the five flavors is associated with one of the five Wu Xing organ systems and one of the five seasons:

A botanical that expresses all five flavors was traditionally interpreted as having tonifying action on all five Wu Xing organ systems, making Schisandra one of the "superior class" herbs in the ancient Shen Nong Ben Cao Jing — appropriate for long-term use to nourish all organ systems rather than for treatment of a single acute condition.

This traditional five-flavor framework is striking when compared with the modern pharmacological picture: Schisandra has documented effects on the liver (sour/Wood), cardiovascular system (bitter/Fire), digestive function (sweet/Earth), respiratory tract (pungent/Metal), and adrenal/HPA-axis function which in TCM falls under the Kidney/Water phase (salty/Water). The ancient sensory observation correctly identified a botanical with multi-organ pharmacological action, anticipating what modern lignan biochemistry would document two thousand years later.

Back to Table of Contents

The Lazarev Adaptogen Definition (1947)

The modern concept of an "adaptogen" was formalized in 1947 by Nikolai Vasilyevich Lazarev (1895-1974), a Soviet pharmacologist initially working at the Tomsk Polytechnic Institute on agents that increased resistance to chemical poisoning, radiation, and physical stress. Lazarev defined an adaptogen as a substance that meets three criteria:

  1. Non-specific resistance — the substance produces a state of non-specifically increased resistance to a wide range of physical, chemical, and biological stressors, rather than acting against any one particular stressor.
  2. Normalizing action — the substance has a normalizing effect on physiology regardless of the direction of pathological change, lowering elevated function and raising depressed function toward homeostatic norms.
  3. Innocuousness — the substance does not disturb normal body function more than required by the normalizing effect, and is safe enough to be used over extended periods without significant toxicity.

By this strict definition, true adaptogens are uncommon — many botanicals are tonics, stimulants, or anti-inflammatories without meeting all three criteria. Schisandra chinensis, Eleutherococcus senticosus, and Rhodiola rosea emerged from Lazarev's screening program as the three botanicals most clearly meeting all three criteria, with Panax ginseng sometimes included as a fourth though debated.

The Lazarev framework is a useful reference point because it imposes a higher standard than the loose contemporary usage of "adaptogen" as a marketing term. A genuine adaptogen should produce measurable, bidirectional normalization of physiology under stress, not simply mild stimulation or sedation.

Back to Table of Contents

The Soviet Adaptogen Research Program (1940s-1991)

Lazarev's student Israel I. Brekhman (1921-1994) led the operational adaptogen research program from the All-Union Pharmaceutical Chemistry Institute and later the Far East Scientific Center of the USSR Academy of Sciences in Vladivostok. The Vladivostok location was strategic: the Russian Far East taiga around Vladivostok is the natural habitat of all three principal adaptogen species — Schisandra, Eleuthero, and Rhodiola.

The Soviet adaptogen research program covered several domains over roughly fifty years:

The Soviet trials were largely published in Russian-language journals (Lekarstvennye Sredstva Dal'nego Vostoka, the in-house Vladivostok journal, was the principal venue) and were translated into English only sporadically. Much of this work entered the Western literature only after the 1991 dissolution of the Soviet Union, when Israel Brekhman's senior collaborator Alexander Panossian relocated to Sweden and began publishing English-language reviews summarizing the Soviet body of work. Panossian's 2008 Journal of Ethnopharmacology review on Schisandra (cited in the references below) remains the definitive English-language synthesis of the Soviet program.

The Soviet trial methodology by modern standards was variable — many trials lacked formal randomization, blinding, or pre-registered endpoints — but the size and consistency of the literature, the unusual diversity of operational settings, and the long-term follow-up provide a substantial cumulative evidence base that is difficult to dismiss despite the methodological caveats.

Back to Table of Contents

Schisandra Alongside Eleuthero and Rhodiola — The Three Pillars

Within the Soviet program, three botanicals were considered the principal adaptogens, each with a slightly different clinical and physiological profile:

The three are not interchangeable but are clinically complementary. The standardized combination formula ADAPT-232 / SHR-5 (developed by the Swedish Herbal Institute, with which Panossian was affiliated post-1991) combines Schisandra, Rhodiola, and Eleuthero in a single formulation specifically designed to capture the complementary actions. This combination formulation is one of the more widely studied adaptogen products in modern Western literature and is discussed in the combination-formulas section below.

Back to Table of Contents

HPA-Axis Modulation and Cortisol Response

The hypothalamic-pituitary-adrenal (HPA) axis is the master neuroendocrine stress-response system: hypothalamic corticotropin-releasing hormone (CRH) triggers pituitary adrenocorticotropic hormone (ACTH) release, which stimulates adrenal cortisol secretion. The adaptogenic action of Schisandra and related botanicals is now understood to operate substantially through HPA-axis modulation.

Multiple animal studies and a smaller number of human studies have documented that Schisandra and the ADAPT-232 combination formula attenuate the cortisol overshoot in response to acute stress. In a typical experimental paradigm, animals (or human subjects) exposed to a standardized stressor — restraint stress in rodents, public-speaking stress (Trier Social Stress Test) in humans — show a peak salivary or serum cortisol elevation typically 2-3 fold above baseline, decaying over 60-90 minutes. Adaptogen pretreatment reduces the peak cortisol elevation by approximately 20-40% without abolishing the stress response entirely — consistent with the Lazarev "normalizing" criterion of dampening pathological excursion without disrupting the healthy underlying response.

The mechanism of cortisol modulation operates at multiple levels:

  1. Central CRH neuron sensitivity — reduced hypothalamic CRH release in response to standardized stressors, mediated through GABAergic and serotonergic afferent modulation
  2. Adrenal cortex sensitivity to ACTH — modest reduction in zona fasciculata responsiveness to ACTH stimulation
  3. Cortisol receptor sensitization — possibly increased glucocorticoid receptor function in feedback-inhibitory pathways, allowing more efficient negative feedback at lower cortisol levels
  4. Stress-protein induction — HSP70 (heat shock protein 70) induction in stress-target tissues, reducing the downstream damage from cortisol and inflammatory mediator release

For more on the broader stress-response physiology and complementary interventions, see our Stress Management page. The Schisandra effect on HPA-axis stress modulation is complementary to behavioral interventions (mindfulness, exercise, sleep hygiene) and pharmacological interventions (low-dose SSRI, low-dose buspirone) where indicated, not a substitute for them.

Back to Table of Contents

Pilot Trials in Mental Performance Under Stress

The most consistent body of human trial evidence for Schisandra adaptogenic action is in mental performance under stress, particularly in operator-error and sleep-deprivation paradigms.

Panossian and colleagues at the Swedish Herbal Institute, between 1999 and 2010, conducted a series of small randomized double-blind placebo-controlled trials on Schisandra or the ADAPT-232 combination in subjects performing mentally demanding tasks under stress. A representative finding from one of the cleaner trials (Aslanyan et al., Phytomedicine 2010): subjects performing the Schulte table (a number-search visual attention task) and a computerized perceptual-discrimination task showed roughly 15-20% improvement in completion speed without loss of accuracy in the adaptogen group versus placebo, with the effect emerging within 1-2 hours of a single oral dose and persisting through the testing period.

Related trials in night-shift physicians, military personnel during sleep deprivation, and university students during examination periods have produced broadly similar effects: improvements in attention, working memory, and self-reported mental clarity, with reductions in subjective fatigue ratings on standardized scales (Profile of Mood States, Fatigue Severity Scale). The effect sizes are modest — nothing like the effects of caffeine on alertness — but they are reproducible across multiple trial settings and are accompanied by the normalizing cortisol and stress-marker changes discussed in the previous section.

The cognitive-stress applications overlap substantially with the dedicated Cognitive Function deep-dive, which discusses the neuroprotective and AChE-inhibition mechanisms in more detail. The adaptogenic mental-performance effect is conceptually distinct from cognitive enhancement in unstressed conditions — Schisandra does not appear to function as a true nootropic in well-rested healthy subjects, but rather as a stress-protective and fatigue-resistant agent that preserves performance under conditions that would otherwise degrade it.

Back to Table of Contents

Nitric Oxide, HSP70, and the Stress-Protein Response

A specific molecular mechanism for the adaptogenic effect, worked out by Panossian and colleagues in vitro and in animal models, centers on nitric oxide (NO) signaling and heat shock protein 70 (HSP70) induction.

Nitric oxide — Schisandrin B and related lignans modulate inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS), with the net effect of reducing pathological NO overproduction during chronic stress while maintaining baseline NO signaling. Excess NO produced during chronic stress contributes to mitochondrial dysfunction (NO inhibits cytochrome c oxidase competitively with oxygen), endothelial dysfunction, and neuroinflammation. Schisandra normalization of NO production is one mechanism by which chronic stress-related fatigue and cardiovascular sequelae are reduced.

Heat shock protein 70 (HSP70 / HSP72) — HSP70 is the principal stress-response chaperone protein, protecting cellular proteins from heat-, oxidative-, and ischemic-stress denaturation. Schisandrin B induces HSP70 expression in liver, heart, and central nervous system tissue, providing a pre-conditioned state in which cells are more resistant to subsequent stress insults. This stress-preconditioning effect is one mechanism by which Schisandra pre-treatment improves outcomes in experimental models of ischemia-reperfusion injury, both in liver and in heart preparations.

The HSP70 and NO modulation mechanisms operate alongside the glutathione/Nrf2 mechanism described in the Liver Protection deep-dive. Together they constitute the molecular core of the adaptogenic phenomenon: a coordinated upregulation of cellular and physiological defenses that improves resilience to subsequent stress without altering baseline function in unstressed conditions.

Back to Table of Contents

Chronic Fatigue and Burnout Applications

The contemporary clinical application of Schisandra as an adaptogen is most commonly in chronic fatigue states — including occupation-related burnout, post-viral fatigue, chronic fatigue syndrome (myalgic encephalomyelitis, ME/CFS), and the fatigue accompanying convalescence from prolonged illness or surgery. The evidence base is mixed and heterogeneous, but suggests modest benefit in the population of patients with persistent fatigue and impaired daytime function in the absence of a clear-cut treatable medical cause.

Typical clinical regimens involve:

For ME/CFS specifically, Schisandra and other adaptogens are sometimes used as part of broader functional-medicine protocols including Fatigue assessment, mitochondrial-support nutrients (coenzyme Q10, magnesium, B-vitamins), and pacing/graded-activity protocols. There is no strong evidence that Schisandra alone produces meaningful remission of ME/CFS, but it appears to be one of several useful tools in a comprehensive program.

For burnout (occupational stress with emotional exhaustion, depersonalization, and reduced personal accomplishment) the evidence is also modest but generally positive. The HPA-axis normalization and cortisol modulation effects are mechanistically appropriate for the dysregulated cortisol patterns commonly seen in burnout (often a flattened diurnal slope with elevated evening cortisol and reduced morning cortisol).

Back to Table of Contents

Combination Adaptogen Formulas (ADAPT-232 / SHR-5)

The standardized adaptogen combination ADAPT-232 (also marketed as Chisan or SHR-5) was developed by the Swedish Herbal Institute under Alexander Panossian and remains one of the more rigorously studied adaptogen products in Western literature. The formulation contains a standardized combination of:

The rationale for the combination is the complementary action of the three botanicals: Rhodiola for cognitive and mood support, Schisandra for hepatic and stress-protein support, Eleuthero for energy and immune-support effects. Several randomized trials have evaluated ADAPT-232 in chronic fatigue, post-viral asthenia, and operator-performance settings, with generally consistent modest benefit relative to placebo on fatigue scales, attention tasks, and quality-of-life measures.

The combination approach has both advantages and disadvantages relative to single-herb dosing. Advantages: complementary mechanisms, ability to use moderate doses of each component (reducing single-component side-effect risk), simplified dosing for the patient. Disadvantages: difficulty attributing effects to any single component, multiplied drug-interaction profile (the CYP3A4 induction caution from Schisandra applies to any combination formula containing it), and inability to titrate components independently.

Back to Table of Contents

Cautions and Practical Dosing

Back to Table of Contents

Key Research Papers

  1. Panossian A, Wikman G (2008). Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicine. Journal of Ethnopharmacology 118(2):183-212. — PubMed
  2. Panossian A, Wikman G (2010). Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress-Protective Activity. Pharmaceuticals 3(1):188-224. — PubMed
  3. Aslanyan G, Amroyan E, Gabrielyan E, et al. (2010). Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions. Phytomedicine 17(7):494-499. — PubMed
  4. Panossian A, Wikman G, Wagner H (1999). Plant adaptogens. III. Earlier and more recent aspects and concepts on their mode of action. Phytomedicine 6(4):287-300. — PubMed
  5. Hancke JL, Burgos RA, Ahumada F (1999). Schisandra chinensis (Turcz.) Baill. Fitoterapia 70(5):451-471. — PubMed
  6. Panossian A, Wikman G, Kaur P, Asea A (2009). Adaptogens exert a stress-protective effect by modulation of expression of molecular chaperones. Phytomedicine 16(6-7):617-622. — PubMed
  7. Panossian A, Hambardzumyan M, Hovhanissyan A, Wikman G (2007). The adaptogens Rhodiola and Schizandra modify the response to immobilization stress in rabbits by suppressing the increase of phosphorylated stress-activated protein kinase, nitric oxide and cortisol. Drug Target Insights 2:39-54. — PubMed
  8. Lu Y, Chen DF (2009). Analysis of Schisandra chinensis and Schisandra sphenanthera. Journal of Chromatography A. — PubMed
  9. Hernandez-Santana A, Perez-Lopez V, Zubeldia JM, Jimenez-Del-Rio M (2014). A Rhodiola rosea root extract protects skeletal muscle cells against chemically induced oxidative stress by modulating heat shock protein 70 (HSP70) expression. Phytotherapy Research. — PubMed
  10. Panossian A, Wikman G, Sarris J (2010). Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. — PubMed
  11. Brekhman II, Dardymov IV (1969). New substances of plant origin which increase nonspecific resistance. Annual Review of Pharmacology 9:419-430. — PubMed
  12. Wagner H, Norr H, Winterhoff H (1994). Plant adaptogens. Phytomedicine 1(1):63-76. — PubMed

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents